These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 843754)

  • 1. Co-operativity in ligand binding to dihydrofolate reductase [proceedings].
    Birdsall B; Burgen AS; Feeney J; Rodriguez de Miranda JF; Roberts GC
    Br J Pharmacol; 1977 Mar; 59(3):521P. PubMed ID: 843754
    [No Abstract]   [Full Text] [Related]  

  • 2. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate.
    Schlegel HB; Poe M; Hoogsteen K
    Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight binding ligand approach to oligosaccharide-grafted protein.
    Totani K; Matsuo I; Ito Y
    Bioorg Med Chem Lett; 2004 May; 14(9):2285-9. PubMed ID: 15081026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR studies of interactions of ligands with dihydrofolate reductase.
    Feeney J
    Biochem Pharmacol; 1990 Jul; 40(1):141-52. PubMed ID: 2196881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.
    Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R
    J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
    Hamrell M; Laszlo J; Brown OE; Sedwick WD
    Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate binding to dihydrofolate reductase.
    Roberts GC; Feeney J; Birdsall B; Charlton P; Young D
    Nature; 1980 Jul; 286(5770):309. PubMed ID: 7402318
    [No Abstract]   [Full Text] [Related]  

  • 11. Presentation of ligands on hydroxylapatite.
    Chu BC; Orgel LE
    Bioconjug Chem; 1997; 8(2):103-5. PubMed ID: 9095348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, energetics and dynamics of ligand binding to dihydrofolate reductase.
    Dauber P; Osguthorpe DJ; Hagler AT
    Biochem Soc Trans; 1982 Oct; 10(5):312-8. PubMed ID: 7141085
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational automatic search method for stable docking models of protein and ligand.
    Mizutani MY; Tomioka N; Itai A
    J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 13C nuclear magnetic resonance study of the interaction of ligands with arginine residues in dihydrofolate reductase.
    Cocco L; Blakley RL; Walker TE; London RE; Matwiyoff NA
    Biochem Biophys Res Commun; 1977 May; 76(1):183-8. PubMed ID: 17403
    [No Abstract]   [Full Text] [Related]  

  • 15. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 17. A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductase.
    Drake JC; Allegra CJ; Chabner BA
    Biochem Pharmacol; 1986 Apr; 35(7):1212-4. PubMed ID: 3964298
    [No Abstract]   [Full Text] [Related]  

  • 18. Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein.
    Bradrick TD; Beechem JM; Howell EE
    Biochemistry; 1996 Sep; 35(35):11414-24. PubMed ID: 8784197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding of [6-19F]tryptophan-labeled Escherichia coli dihydrofolate reductase in the presence of ligand: a stopped-flow NMR spectroscopy study.
    Hoeltzli SD; Frieden C
    Biochemistry; 1998 Jan; 37(1):387-98. PubMed ID: 9425060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
    Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
    Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.